People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gallant Pet, Inc. | — | Other | Series B | $42.6M | $49.4M | 2022 |
| BiomEdit, Inc. | — | Biotechnology | Series B | $16.0M | $82.1M | 2025 |
Aaron Schacht at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aaron Schacht on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Teymour Boutros-Ghali | 1 | 5 |
| Misti Ushio | 1 | 4 |
| Davis Brimer | 1 | 3 |
| James Ratigan | 1 | 2 |
| Doug Drew | 1 | 2 |
| Richard Jennings | 1 | 2 |
| Aaron Hirschhorn | 1 | 2 |
| Patrick James | 1 | 2 |
| Brett Wong | 1 | 1 |
| Bruce Schelkopf | 1 | 1 |
| Barbara Bodem | 1 | 1 |
| Paul Casady | 1 | 1 |
| Linda Black | 1 | 1 |
| Darryl Rawlings | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.